Royce & Associates LP Sangamo Therapeutics, Inc Transaction History

Royce & Associates LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$9.23 - $18.18 $637,396 - $1.26 Million	-69,057 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$9.38 - $12.48 $30,409 - $40,460	3,242 Added 4.93%	69,057 $653,000
Q1 2019 May 09, 2019	SELL	$7.72 - $12.81 $162,120 - $269,010	-21,000 Reduced 24.19%	65,815 $628,000
Q4 2018 Feb 11, 2019	SELL	$9.51 - $16.6 $513,540 - $896,400	-54,000 Reduced 38.35%	86,815 $997,000
Q3 2018 Nov 13, 2018	SELL	$13.05 - $19.05 $1.5 Million - $2.19 Million	-115,000 Reduced 44.95%	140,815 $2.39 Million
Q2 2018 Aug 09, 2018	BUY	$13.9 - $19.8 $988,985 - $1.41 Million	71,150 Added 38.53%	255,815 $3.63 Million
Q1 2018 May 14, 2018	SELL	$16.7 - $26.35 $2.44 Million - $3.86 Million	-146,300 Reduced 44.2%	184,665 $3.51 Million
Q4 2017 Feb 09, 2018	SELL	$11.6 - $17.35 $1.71 Million - $2.56 Million	-147,500 Reduced 30.83%	330,965 $5.43 Million
Q3 2017 Nov 13, 2017	SELL	$8.4 - $15.0 $2.29 Million - $4.09 Million	-272,635 Reduced 36.3%	478,465 $7.18 Million
Q2 2017 Aug 07, 2017	BUY	N/A	751,100	751,100 $6.61 Million

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $178M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.